Practice question

Answer the question and get instant feedback.

MediumEndocrinologyOsteoporosis Managementukmlamrcgp aktpaneprescribing safety assessment

A 66-year-old woman with osteoporosis (diagnosed on DEXA scan, T-score -2.8 at hip) is intolerant of oral bisphosphonates due to severe oesophagitis. She has no history of VTE or breast cancer. Her renal function is normal. What is the most appropriate next-line pharmacological treatment according to NICE TA464 / NG146?

Educational content. Not a substitute for clinical judgement or local policy.